News • Prediction of treatment response
Colon and rectal cancer: new biomarker shows which patients benefit from immunotherapy
A multidisciplinary team of pathologists, oncologists and biologists has discovered a new biomarker to determine whether immunotherapy may work in people with colon and rectal cancer.






































